[Federal Register Volume 66, Number 215 (Tuesday, November 6, 2001)]
[Notices]
[Pages 56111-56112]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-27752]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Interagency Autism Coordinating Committee; Notice of Meeting

    The Children's Health Act of 2000 (Pub. L. 106-310), Title I, 
section 104, mandated the establishment of an Interagency Autism 
Coordinating Committee (IACC) to coordinate autism research and other 
efforts within the Department of Health and Human Services (DHHS). In 
April 2001, Secretary Tommy Thompson delegated the authority to 
establish the IACC to the National Institutes of Health (NIH). The 
National Institute of Mental Health (NIMH) at the NIH has been 
designated the lead for this activity.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other

[[Page 56112]]

reasonable accommodations, should notify the contact person listed 
below in advance of the meeting.


    Name of Committee: Interagency Autism Coordinating Committee.
    Date: November 19, 2001.
    Time: 9 a.m. to 4:30 p.m.
    Agenda: Discussion of autism activities across Federal agencies.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31, Conference Room 10 (6th floor), Bethesda, Maryland 
20892,
    Contact Person: Kimberly Hoagwood, Ph.D., Associate Director for 
Child and Adolescent Research, National Institute of Mental Health, 
NIH, 6001 Executive Boulevard, Room 7167, MSC 9630, Bethesda, 
Maryland 20892, Email: [email protected] Telephone: (301) 443-4627.
    Any member of the public interested in presenting oral comments 
to the committee may notify the contact person listed on this notice 
at least 5 days in advance of the meeting. Interested individuals 
and representatives of organizations may submit a letter of intent, 
a brief description of the organization represented, and a short 
description of the oral presentation. Presentations may be limited 
to 5 minutes; both printed and electronic copies are requested for 
the record. In addition, any interested person may file written 
comments with the committee by forwarding his/her statement to the 
contact person listed on this notice. The statement should include 
the name, address, telephone number and, when applicable, the 
business or professional affiliation of the interested person.
    Information is also available on the NIMH homepage at http://www.nimh/nih/gov/events/interagencyautism.cfm>.

    Dated: October 30, 2001.
Yvonne Maddox,
Acting Deputy Director, National Institutes of Health.
[FR Doc. 01-27752 Filed 11-5-01; 8:45 am]
BILLING CODE 4140-01-M